Figure 3 — A new signature based on alternative polyadenylation for prognostic prediction and therapeutic responses in low-grade glioma

Research Paper|Volume 14, Issue 2|pp. 826–844

A new signature based on alternative polyadenylation for prognostic prediction and therapeutic responses in low-grade glioma

Back to articleFigure 3(3 of 10)

100%

Figure 3.Development and validation of a four-APA-based prognostic signature. The risk score distribution, gene expression, and LGG patients’ survival status in the training (A–C), test (D–F), and whole sets (G–I) based on the signature.